GC
CNST

Guggenheim Capital’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Guggenheim Capital’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-21,553
Closed -$728K – 2277
2021
Q2 		$728K Buy
+21,553
New +$549K ﹤0.01% 1652

Guggenheim Capital's CNST Position: Q3 2021 in Review

Guggenheim Capital sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 21,553 shares — an estimated $728K sold.

Guggenheim Capital first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $728K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Guggenheim Capital reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Guggenheim Capital sold 21,553 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $728K.
  • Guggenheim Capital first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
  • Guggenheim Capital's Constellation Pharmaceuticals, Inc. position peaked at $728K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Guggenheim Capital's 13F filing for Q3 2021, filed 15 Nov 2021.